empower pharmacy eli lilly

News

Eli Lilly Has Its Next Billion-Dollar Weight Loss Drug

Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes drug Mounjaro and weight loss drug Zepbound,

Houston Public Media · 3d

Eli Lilly sues Houston-based compounding pharmacy over alleged ‘knockoff’ obesity, diabetes drugs

Eli Lilly’s legal actions against Empower Pharmacy and other compounding pharmacies come several months after the FDA announced that a shortage of Mounjaro and Zepbound had been resolved.

Health News Florida · 3d

Eli Lilly sues companies selling alternative versions of its weight loss drug

The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of its drug Zepbound.

Fierce Pharma2d

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the ...

Eli Lilly Files Slew of Lawsuits Over Zepbound and Mounjaro

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...

Pharmaceutical Technology on MSN3d

Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

NBC Los Angeles26d

Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro

Eli Lilly is suing two pharmacies for compounding ... Lilly alleges the two companies — Strive Pharmacy and Empower Pharmacy — are falsely marketing their products as personalized versions ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results